Clinical trials
Observational Malaria, Vivax trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2013 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Unknown status | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Research Institute for Tropical Medicine, Philippines | 2 |
| University of Oxford | 2 |
| Dr. Prayuth Sudathip | 1 |
| Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 1 |
| Medicines for Malaria Venture | 1 |
| Menzies School of Health Research | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| National Malaria Control Programme, Madagascar | 1 |
| University Hospital, Gentofte, Copenhagen | 1 |
| University Hospital, Strasbourg, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria, Vivax | 13 |
| Malaria | 6 |
| Malaria, Falciparum | 5 |
| Glucosephosphate Dehydrogenase Deficiency | 2 |
| Cardiovascular Diseases | 1 |
| Communicable Diseases | 1 |
| Fever | 1 |
| Heart Diseases | 1 |
| Protozoan Infections | 1 |
| Recurrence | 1 |
Trials
Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.